11
Participants
Start Date
February 14, 2024
Primary Completion Date
February 14, 2026
Study Completion Date
July 1, 2026
Brentuximab vedotin
Dose 0.6mg/kg will be given every 3 weeks for 16 cycles (48 weeks), in addition to standard of care medications for SSc that may include cyclophosphamide, methotrexate, azathioprine, mycophenolate mofetil (MMF, cellcept) and mycophenolic acid (myfortic)
RECRUITING
Rheumatology Clinic, St. Joseph's Health Care, London
Collaborators (1)
Seattle Genetics (now a wholly owned subsidiary of Pfizer)
UNKNOWN
Pfizer
INDUSTRY
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER